<!DOCTYPE html PUBLIC "-//WAPFORUM//DTD XHTML Mobile 1.0//EN" "http://www.wapforum.org/DTD/xhtml-mobile10.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
<meta id="viewport" name="viewport" content="width=deivce-width,initial-scale=1,maximum-scale=1,user-scalable=0;" />
<title>急性肾损伤AKI诊断和分期标准(KDIGO, 2012)</title>
<link href="Pub/css/layout.css" rel="stylesheet" type="text/css" />
<link href="Pub/css/public.css" rel="stylesheet" type="text/css" />
<script type="text/javascript" src="Pub/js/jquery-1.6.1.min.js"></script>
<script type="text/javascript" src="Pub/js/base.js"></script>
</head>

<body>
<div id="Layout">
	<div class="titleBar">
		<h1>急性肾损伤AKI诊断和分期标准(KDIGO, 2012)</h1>
	</div>
	<div class="mainContainer">
		<form action="" method="post">
			<table border="0" cellspacing="0" cellpadding="0" class="countTab2">
            	<thead>
                	<tr>
                    	<th>AKI诊断标准：</th>
                    </tr>
                	<tr>
                        <th>符合以下情况之一者即可被诊断为AKI：</th>
                    </tr>
                </thead>
				<tbody>
                    <tr>
                        <td>①48小时内Scr升高超过26.5μmol/L(0.3mg/dl)；</td>
                    </tr>
                    <tr>
                        <td>②Scr升高超过基线1.5倍——确认或推测为7天内发生；</td>
                    </tr>
                    <tr>
                        <td>③尿量＜0.5ml/(kg·h)，且持续6小时以上。</td>
                    </tr>
                </tbody>
            </table>
			<table border="0" cellspacing="0" cellpadding="0" class="countTab2">
            	<thead>
                	<tr>
                    	<th colspan="3">AKI分期标准：</th>
                    </tr>
                	<tr>
                        <th>分期</th>
                        <th>Scr</th>
                        <th>尿量</th>
                    </tr>
                </thead>
				<tbody>
                    <tr>
                        <th>1期</th>
                        <td>升高为基线的1.5~1.9倍，或<br />升高超过26.5μmol/L(0.3mg/dl)</td>
                        <td>&lt;0.5ml/(kg·h) 持续6~12h</td>
                    </tr>
                    <tr>
                    	<th>2期</th>
                        <td>升高为基线的2.0~2.9倍</td>
                        <td>&lt;0.5ml/(kg·h) &ge;12h</td>
                    </tr>
                    <tr>
                    	<th>3期</th>
                        <td>升高为基线的3倍，或<br />绝对值&ge;353.6μmol/L(4.0mg/dl)，或<br />开始使用肾脏替代治疗，或<br />患者&lt;18岁且eGFR&lt;35ml/(min·1.73m<sup>2</sup>)</td>
                        <td>&lt;0.3ml/(kg·h) &ge;24h，或<br />无尿&ge;12h</td>
                    </tr>
                </tbody>
            </table>
            <table width="90%" border="0" cellspacing="0" cellpadding="0" class="countTab2">
              <tbody>
                    <tr>
                        <th>结果解读</th>
                        <td>根据AKI分期的推荐处理如下：<br /><img src="Pub/images/AKI.jpg" /></td>
                    </tr>
                    <tr>
                        <th>相关解释</th>
                        <td>1.单用尿量改变作为诊断标准时，需要除外尿路梗阻及其他导致尿量减少的原因。<br />2.指南推荐血清肌酐和尿量仍然作为AKI最好的标志物（ⅠB）。</td>
                    </tr>
                    <tr>
                        <th>参考来源</th>
                        <td>1. KDIGO Clinical Practice Guideline for Acute Kidney Injury. 2012.3. http://www.kidney-international.org<br />2. 图片作者：大连医科大学附属第一医院 重症医学科 李青栋</td>
                    </tr>
                </tbody>
            </table>
		</form>
	</div>
</div>
</body>
</html>
